ESPANOL SUBUTEX NO FURTHER A MYSTERY

The concomitant utilization of buprenorphine and CYP3A4 inducers can minimize the plasma concentration of buprenorphine [see CLINICAL PHARMACOLOGY], perhaps leading to diminished efficacy or onset of the withdrawal syndrome in individuals who have developed physical dependence to buprenorphine.All trials used buprenorphine in conjunction with psych